Signaling mechanisms that regulate ex vivo survival of human acute myeloid leukemia initiating cells

Signaling mechanisms that regulate ex vivo survival of human acute myeloid leukemia initiating cells Bhavanasi et al. Blood Cancer Journal (2017) 7:636 DOI 10.1038/s41408-017-0003-1 Blood Cancer Journal CORRESPONDENCE Open Access Signaling mechanisms that regulate ex vivo survival of human acute myeloid leukemia initiating cells 1 1,4 2 1 1 1 Dheeraj Bhavanasi ,KwunWah Wen ,Xiaolei Liu , Francois Vergez , Gwenn Danet-Desnoyers , Martin Carroll , 3 1 Jian Huang and Peter S Klein Acute myeloid leukemia (AML) is an aggressive malig- of engrafting immunocompromised mice, identifying a nancy of the hematopoietic system that arises through signaling network that regulates the viability of LICs. clonal expansion of myeloid precursor cells that have As GSK-3 inhibition expands hematopoietic stem and arrested at an early stage of differentiation and ultimately progenitor cells and Gsk3 knockout causes a myelopro- causes death in over 50% of patients. Despite the liferative neoplasm suggestive of AML in mice , we tested aggressive growth characteristics of AML in vivo, AML whether direct inhibition of GSK-3 would enhance the blasts are difficult to culture once removed from the viability of primary AML cells ex vivo. AML cells in cul- patient, suggesting that AML cells depend on signals from ture do not proliferate and typically die over a few days. 1,2 the http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Blood Cancer Journal Springer Journals

Signaling mechanisms that regulate ex vivo survival of human acute myeloid leukemia initiating cells

Loading next page...
 
/lp/springer_journal/signaling-mechanisms-that-regulate-ex-vivo-survival-of-human-acute-bztmvDW95W
Publisher
Nature Publishing Group UK
Copyright
Copyright © 2017 by The Author(s)
Subject
Biomedicine; Biomedicine, general; Cancer Research; Oncology; Hematology
eISSN
2044-5385
D.O.I.
10.1038/s41408-017-0003-1
Publisher site
See Article on Publisher Site

Abstract

Bhavanasi et al. Blood Cancer Journal (2017) 7:636 DOI 10.1038/s41408-017-0003-1 Blood Cancer Journal CORRESPONDENCE Open Access Signaling mechanisms that regulate ex vivo survival of human acute myeloid leukemia initiating cells 1 1,4 2 1 1 1 Dheeraj Bhavanasi ,KwunWah Wen ,Xiaolei Liu , Francois Vergez , Gwenn Danet-Desnoyers , Martin Carroll , 3 1 Jian Huang and Peter S Klein Acute myeloid leukemia (AML) is an aggressive malig- of engrafting immunocompromised mice, identifying a nancy of the hematopoietic system that arises through signaling network that regulates the viability of LICs. clonal expansion of myeloid precursor cells that have As GSK-3 inhibition expands hematopoietic stem and arrested at an early stage of differentiation and ultimately progenitor cells and Gsk3 knockout causes a myelopro- causes death in over 50% of patients. Despite the liferative neoplasm suggestive of AML in mice , we tested aggressive growth characteristics of AML in vivo, AML whether direct inhibition of GSK-3 would enhance the blasts are difficult to culture once removed from the viability of primary AML cells ex vivo. AML cells in cul- patient, suggesting that AML cells depend on signals from ture do not proliferate and typically die over a few days. 1,2 the

Journal

Blood Cancer JournalSpringer Journals

Published: Nov 30, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve Freelancer

DeepDyve Pro

Price
FREE
$49/month

$360/year
Save searches from
Google Scholar,
PubMed
Create lists to
organize your research
Export lists, citations
Read DeepDyve articles
Abstract access only
Unlimited access to over
18 million full-text articles
Print
20 pages/month
PDF Discount
20% off